Evolving Evidence in Support of Sentinel Lymph Node Biopsy for Early-Stage Oral Cavity Cancer

Affiliations

¹ Departments of Head and Neck Surgery, Molecular and Cellular Oncology, and Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Departments of Otolaryngology, Immunology, and Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA.

Comment

Stephen Y Lai et al. J Clin Oncol. 2020.

. 2020 Dec 1;38(34):3983-3986.

doi: 10.1200/JCO.20.02716. Epub 2020 Oct 14.

¹ Departments of Head and Neck Surgery, Molecular and Cellular Oncology, and Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Departments of Otolaryngology, Immunology, and Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA.

No abstract available

Comment on

Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal Cancer.
Garrel R, Poissonnet G, Moyà Plana A, Fakhry N, Dolivet G, Lallemant B, Sarini J, Vergez S, Guelfucci B, Choussy O, Bastit V, Richard F, Costes V, Landais P, Perriard F, Daures JP, de Verbizier D, Favier V, de Boutray M. Garrel R, et al. J Clin Oncol. 2020 Dec 1;38(34):4010-4018. doi: 10.1200/JCO.20.01661. Epub 2020 Oct 14. J Clin Oncol. 2020. PMID: 33052754 Clinical Trial.